Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.

Wider C, Dachsel JC, Soto AI, Heckman MG, Diehl NN, Yue M, Lincoln S, Aasly JO, Haugarvoll K, Trojanowski JQ, Papapetropoulos S, Mash D, Rajput A, Rajput AH, Gibson JM, Lynch T, Dickson DW, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Mov Disord. 2009 Feb 15;24(3):455-9. doi: 10.1002/mds.22442.

2.

[Analysis of the rs12720208 single-nucleotide polymorphism of the FGF20 gene in Russian patients with sporadic Parkinson's disease].

Ustinova VV, Shadrina MI, Fedotova EIu, Illarioshkin SN, Limborskaia SA, Slominskiĭ PA.

Genetika. 2012 Dec;48(12):1437-9. Russian.

PMID:
23516905
3.

FGF20 rs12720208 SNP and microRNA-433 variation: no association with Parkinson's disease in Spanish patients.

de Mena L, Cardo LF, Coto E, Miar A, Díaz M, Corao AI, Alonso B, Ribacoba R, Salvador C, Menéndez M, Morís G, Alvarez V.

Neurosci Lett. 2010 Jul 19;479(1):22-5. doi: 10.1016/j.neulet.2010.05.019. Epub 2010 May 13.

PMID:
20471450
4.

Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease.

Mizuta I, Tsunoda T, Satake W, Nakabayashi Y, Watanabe M, Takeda A, Hasegawa K, Nakashima K, Yamamoto M, Hattori N, Murata M, Toda T.

Hum Genet. 2008 Aug;124(1):89-94. doi: 10.1007/s00439-008-0525-5. Epub 2008 Jun 22.

PMID:
18568448
5.

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein.

Wang G, van der Walt JM, Mayhew G, Li YJ, Züchner S, Scott WK, Martin ER, Vance JM.

Am J Hum Genet. 2008 Feb;82(2):283-9. doi: 10.1016/j.ajhg.2007.09.021. Epub 2008 Jan 31.

6.

Quantitative assessment of the effect of FGF20 rs12720208 variant on the risk of Parkinson's disease: a meta-analysis.

Wang X, Sun X, Zhang X, Li H, Xie A.

Neurol Res. 2017 Apr;39(4):374-380. doi: 10.1080/01616412.2017.1286542. Epub 2017 Feb 13. Review.

PMID:
28191856
7.

Association between FGF20 rs12720208 gene polymorphism and Parkinson's disease: a meta-analysis.

Zhao X, Wu Y, Zhao C, Feng M.

Neurol Sci. 2016 Jul;37(7):1119-26. doi: 10.1007/s10072-016-2559-0. Epub 2016 Mar 29.

PMID:
27023076
8.

Variation in the miRNA-433 binding site of FGF20 is a risk factor for Parkinson's disease in Iranian population.

Haghnejad L, Emamalizadeh B, Jamshidi J, Bidoki AZ, Ghaedi H, Ahmadi E, Abdollahi S, Shahmohammadibeni N, Taghavi S, Fazeli A, Motallebi M, Zarneh AE, Mohammadihosseinabad S, Abbaszadegan MR, Torkamandi S, Gavenaroudi MA, Pedram N, Shahidi GA, Tafakhori A, Darvish H, Movafagh A.

J Neurol Sci. 2015 Aug 15;355(1-2):72-4. doi: 10.1016/j.jns.2015.05.020. Epub 2015 May 27.

PMID:
26070653
9.

Fibroblast growth factor 20 polymorphism in sporadic Parkinson's disease in Northern Han Chinese.

Xu X, Wang N, Xu H, Xie A, Jiang H, Xie J.

J Clin Neurosci. 2013 Nov;20(11):1588-90. doi: 10.1016/j.jocn.2013.02.023. Epub 2013 Aug 9.

PMID:
23938014
10.

Fibroblast growth factor 20 (FGF20) polymorphism is a risk factor for Parkinson's disease in Chinese population.

Pan J, Li H, Wang Y, Ma JF, Zhang J, Wang G, Liu J, Wang XJ, Xiao Q, Chen SD.

Parkinsonism Relat Disord. 2012 Jun;18(5):629-31. doi: 10.1016/j.parkreldis.2012.01.017. Epub 2012 Feb 18.

PMID:
22342445
11.

Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients.

Clarimon J, Xiromerisiou G, Eerola J, Gourbali V, Hellström O, Dardiotis E, Peuralinna T, Papadimitriou A, Hadjigeorgiou GM, Tienari PJ, Singleton AB.

BMC Neurol. 2005 Jun 20;5:11.

12.

Fibroblast growth factor 20 (FGF20) gene polymorphism and risk of Parkinson's disease: a meta-analysis.

Zhu R, Zhu Y, Liu X, He Z.

Neurol Sci. 2014 Dec;35(12):1889-94. doi: 10.1007/s10072-014-1853-y. Epub 2014 Jun 19.

PMID:
24942208
13.
14.

Fibroblast growth factor 20 gene and Parkinson's disease in the Japanese population.

Satake W, Mizuta I, Suzuki S, Nakabayashi Y, Ito C, Watanabe M, Takeda A, Hasegawa K, Sakoda S, Yamamoto M, Hattori N, Murata M, Toda T.

Neuroreport. 2007 Jun 11;18(9):937-40.

PMID:
17515805
15.

alpha-Synuclein promoter RsaI T-to-C polymorphism and the risk of Parkinson's disease.

Wang CK, Chen CM, Chang CY, Chang KH, Chen IC, Li ML, Lee-Chen GJ, Wu YR.

J Neural Transm (Vienna). 2006 Oct;113(10):1425-33. Epub 2006 Apr 11.

PMID:
16604306
16.

Genetic analysis of FGF20 variants in Chinese Han patients with essential tremor.

Yuan L, Song Z, Deng X, Zheng W, Yang Z, Yang Y, Deng H.

Neurosci Lett. 2016 May 4;620:159-62. doi: 10.1016/j.neulet.2016.03.055. Epub 2016 Mar 31.

PMID:
27040428
17.

Genetic variation in FGF20 modulates hippocampal biology.

Lemaitre H, Mattay VS, Sambataro F, Verchinski B, Straub RE, Callicott JH, Kittappa R, Hyde TM, Lipska BK, Kleinman JE, McKay R, Weinberger DR.

J Neurosci. 2010 Apr 28;30(17):5992-7. doi: 10.1523/JNEUROSCI.5773-09.2010.

18.

Gene-gene interaction between FGF20 and MAOB in Parkinson disease.

Gao X, Scott WK, Wang G, Mayhew G, Li YJ, Vance JM, Martin ER.

Ann Hum Genet. 2008 Mar;72(Pt 2):157-62. doi: 10.1111/j.1469-1809.2007.00418.x. Epub 2008 Jan 20.

19.

Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population.

Rajput A, Vilariño-Güell C, Rajput ML, Ross OA, Soto-Ortolaza AI, Lincoln SJ, Cobb SA, Heckman MG, Farrer MJ, Rajput A.

Mov Disord. 2009 Dec 15;24(16):2411-4. doi: 10.1002/mds.22795.

PMID:
19890971
20.

Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.

Kobayashi H, Ujike H, Hasegawa J, Yamamoto M, Kanzaki A, Sora I.

Mov Disord. 2006 Dec;21(12):2157-64.

PMID:
17078049

Supplemental Content

Support Center